AI-Powered heart screening on your phone: a new way to catch hidden heart disease in families
NCT ID NCT06609174
First seen Nov 05, 2025 · Last updated Apr 28, 2026 · Updated 20 times
Summary
This study looked at whether a mobile ECG device, analyzed by artificial intelligence, can help screen close relatives of people with dilated cardiomyopathy (a weakened heart muscle). 119 participants used a Kardia 6-lead device to send their heart signals to the cloud for AI analysis. The goal was to see how many relatives completed the screening and if the AI could detect low heart pumping function (ejection fraction ≤45%). This approach could make heart screening easier and more accessible for at-risk families.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CARDIOMYOPATHY are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Mayo Clinic in Rochester
Rochester, Minnesota, 55905, United States
Conditions
Explore the condition pages connected to this study.